Paclitaxel and Irinotecan in Advanced Gastric Cancer
NCT01136031
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Cancer
Interventions
DRUG:
Paclitaxel and irinotecan
Sponsor
Seoul National University Hospital